Tier 3 · Filer Universe
Grace Therapeutics, Inc.
GRCE · Nasdaq · Healthcare. Identity, market observation, SEC facts, and source links remain separate and inspectable.
Price
$2.20
+0.00%
Coverage
Tier 3
Tier 3 · Filer Universe
SEC CIK
0001444192
Liquidity rank
#5227
Observed dollar volume
Tier 3 is a directory treatment. It does not imply options, analyst estimates, or complete company-facts coverage. Missing fields stay missing.
SEC XBRL facts
| Field | Value | Period end | Filing |
|---|---|---|---|
| Annual revenue | Not published | Not published | No matching frame |
| Annual diluted EPS | -0.47 | 2026-03-31 | 0001140361-26-025662 |
| Quarterly revenue | Not published | Not published | No matching frame |
| Quarterly diluted EPS | -0.91 | 2026-06-30 | 0001140361-26-032632 |
SEC EDGAR Frames batch generated 2026-08-23T22:53:06.946Z. Frames are calendar-aligned and may not cover every filer or fiscal period.
Filings and machine access
Latest SEC filingsSEC company browse
SEC submissions JSONDirect upstream record
Per-symbol JSONSame-origin machine contract
Context paths
HealthcareNasdaqBMY · Tier 1 peerISRG · Tier 1 peerHCA · Tier 1 peerAMGN · Tier 1 peer
Provenance
Quote and corporate actionsYahoo Finance chart
FundamentalsSEC EDGAR Frames